Intellia Therapeutics, Inc.
NTLA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652130
In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Intellia Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 348
- −17 vs. Q4 2021
- Shares held
- 65.1M
- +911.1K (+1.4%) vs. Q4 2021
- Total value
- $4.71B
- −$2.88B (−38.0%) vs. Q4 2021
- New holders
- 61
- 96 more added
- Sold out
- 78
- 124 more reduced
7 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 329 | $2.43B |
| Q1 2026 | 306 | $1.41B |
| Q4 2025 | 295 | $938.9M |
| Q3 2025 | 284 | $1.80B |
| Q2 2025 | 283 | $933.8M |
| Q1 2025 | 296 | $720.3M |
| Q4 2024 | 295 | $1.16B |
| Q3 2024 | 284 | $1.92B |
| Q2 2024 | 291 | $2.02B |
| Q1 2024 | 284 | $2.51B |
| Q4 2023 | 293 | $2.60B |
| Q3 2023 | 286 | $2.53B |
| Q2 2023 | 292 | $3.19B |
| Q1 2023 | 291 | $2.93B |
| Q4 2022 | 304 | $2.72B |
| Q3 2022 | 321 | $3.81B |
| Q2 2022 | 301 | $3.44B |
| Q1 2022 | 348 | $4.71B |
| Q4 2021 | 372 | $7.60B |
| Q3 2021 | 366 | $8.34B |
| Q2 2021 | 337 | $10.0B |
| Q1 2021 | 261 | $5.07B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 203,684 | $14.8M | 1.26% | +203,684 | New |
| Temasek Holdings (Private) Ltd | 204,276 | $14.8M | 0.06% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 218,409 | $15.9M | 0.02% | +215,775+8,191.9% | Added |
| Eagle Asset Management Inc | 231,517 | $16.8M | 0.09% | +10,113+4.6% | Added |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 241,396 | $17.5M | 0.03% | −121,000−33.4% | Reduced |
| Polar Capital Holdings Plc | 257,510 | $18.7M | 0.11% | +257,510 | New |
| Artal Group S.A. | 275,000 | $20.0M | 0.84% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 287,909 | $20.9M | 0.81% | +109,687+61.5% | Added |
| Bank of New York Mellon Corp | 294,571 | $21.4M | 0.00% | −1,148−0.4% | Reduced |
| Jennison Associates LLC | 310,036 | $22.5M | 0.02% | −725,362−70.1% | Reduced |
| UBS Asset Management Americas Inc | 319,404 | $23.2M | 0.01% | +30,815+10.7% | Added |
| Nuveen Asset Management, LLC | 339,494 | $23.8M | 0.01% | −15,014−4.2% | Reduced |
| Bank of America Corp | 337,083 | $24.5M | 0.00% | +46,588+16.0% | Added |
| Citigroup Inc | 338,786 | $24.6M | 0.03% | +273,107+415.8% | Added |
| Lord, Abbett & Co. LLC | 362,750 | $26.4M | 0.07% | −584,084−61.7% | Reduced |
| Pictet Asset Management SA | 366,533 | $26.6M | 0.03% | −55,431−13.1% | Reduced |
| Invesco Ltd. | 388,681 | $28.2M | 0.01% | −88,724−18.6% | Reduced |
| Avidity Partners Management LP | 390,075 | $28.3M | 0.63% | +390,075 | New |
| Ameriprise Financial Inc | 432,160 | $31.4M | 0.01% | −5,330−1.2% | Reduced |
| Two Sigma Advisers, LP | 438,017 | $31.8M | 0.08% | +167,300+61.8% | Added |
| Two Sigma Investments, LP | 478,253 | $34.8M | 0.10% | +280,092+141.3% | Added |
| Citadel Advisors LLC | 486,433 | $35.3M | 0.04% | +279,591+135.2% | Added |
| Millennium Management LLC | 500,266 | $36.4M | 0.04% | +489,645+4,610.2% | Added |
| Norges Bank | 500,807 | $36.4M | 0.01% | +59,047+13.4% | Added |
| Goldman Sachs Group Inc | 531,016 | $38.6M | 0.01% | −460,075−46.4% | Reduced |
| Victory Capital Management Inc | 587,931 | $42.0M | 0.04% | −39,566−6.3% | Reduced |
| Federated Hermes, Inc. | 619,600 | $45.0M | 0.10% | +69,210+12.6% | Added |
| JPMorgan Chase & Co | 627,969 | $45.6M | 0.01% | −40,398−6.0% | Reduced |
| Northern Trust Corp | 689,611 | $50.1M | 0.01% | −48,192−6.5% | Reduced |
| Charles Schwab Investment Management Inc | 696,367 | $50.6M | 0.02% | +14,446+2.1% | Added |
| Himension Fund | 744,160 | $54.1M | 5.79% | +153,920+26.1% | Added |
| Wellington Management Group LLP | 778,512 | $56.6M | 0.01% | +167,764+27.5% | Added |
| Dimensional Fund Advisors LP | 945,747 | $68.7M | 0.02% | −111,663−10.6% | Reduced |
| Franklin Resources Inc | 966,638 | $70.2M | 0.03% | −162,943−14.4% | Reduced |
| Discovery Value Fund | 986,173 | $71.7M | 5.28% | −4,579−0.5% | Reduced |
| Chevy Chase Trust Holdings, Inc. | 1,056,768 | $76.8M | 0.26% | −81,336−7.1% | Reduced |
| Geode Capital Management, LLC | 1,226,824 | $89.2M | 0.01% | −5,668−0.5% | Reduced |
| Morgan Stanley | 1,294,999 | $94.1M | 0.01% | −228,254−15.0% | Reduced |
| Alliancebernstein L.P. | 1,747,681 | $127.0M | 0.05% | +285,021+19.5% | Added |
| Price T Rowe Associates Inc | 2,219,871 | $161.3M | 0.02% | +119,523+5.7% | Added |
| State Street Corp | 2,397,527 | $174.2M | 0.01% | +556,076+30.2% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 2,468,760 | $179.4M | 0.73% | +889,224+56.3% | Added |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192.4M | 1.41% | +118,366+4.3% | Added |
| FMR LLC | 2,794,925 | $203.1M | 0.02% | −1,082,848−27.9% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 2,872,269 | $208.7M | 0.14% | +118,366+4.3% | Added |
| BlackRock Inc. | 5,601,739 | $407.1M | 0.01% | −18,637−0.3% | Reduced |
| Vanguard Group Inc | 6,391,940 | $464.5M | 0.01% | −50,415−0.8% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 8,981,029 | $652.7M | 2.73% | +1,064,147+13.4% | Added |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −605,587−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −316,576−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −273,776−100.0% | Sold out |
| Coatue Management LLCSuperinvestorCoatue Management | 0 | $0 | 0.00% | −101,762−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −71,282−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −53,200−100.0% | Sold out |
| Castleark Management LLC | 0 | $0 | 0.00% | −42,075−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −39,889−100.0% | Sold out |
| Goldstream Capital Management Ltd | 0 | $0 | 0.00% | −30,161−100.0% | Sold out |
| Ratan Capital Management LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Myriad Asset Management Ltd. | 0 | $0 | 0.00% | −21,000−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −20,730−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −16,721−100.0% | Sold out |
| Vista Finance, LLC | 0 | $0 | 0.00% | −11,965−100.0% | Sold out |
| Ipswich Investment Management Co., Inc. | 0 | $0 | 0.00% | −10,435−100.0% | Sold out |
| Bamco Inc | 0 | $0 | 0.00% | −10,400−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −9,759−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −8,935−100.0% | Sold out |
| Avitas Wealth Management LLC | 0 | $0 | 0.00% | −8,391−100.0% | Sold out |
| Chartwell Investment Partners, LLC | 0 | $0 | 0.00% | −8,239−100.0% | Sold out |
| MML Investors Services, LLC | 0 | $0 | 0.00% | −8,205−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −7,853−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −7,608−100.0% | Sold out |
| Vienna Asset Management LLC | 0 | $0 | 0.00% | −7,580−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −6,500−100.0% | Sold out |
| HBK Sorce Advisory LLC | 0 | $0 | 0.00% | −4,289−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −4,200−100.0% | Sold out |
| Advisors Asset Management, Inc. | 0 | $0 | 0.00% | −4,005−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −3,661−100.0% | Sold out |
| Illinois Municipal Retirement Fund | 0 | $0 | 0.00% | −3,610−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −3,565−100.0% | Sold out |
| Navellier & Associates Inc | 0 | $0 | 0.00% | −3,532−100.0% | Sold out |
| Level Four Advisory Services, LLC | 0 | $0 | 0.00% | −3,220−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −3,172−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −3,058−100.0% | Sold out |
| Golden Green, Inc. | 0 | $0 | 0.00% | −3,014−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −2,761−100.0% | Sold out |
| National Asset Management, Inc. | 0 | $0 | 0.00% | −2,631−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −2,399−100.0% | Sold out |
| Cobblestone Capital Advisors LLC | 0 | $0 | 0.00% | −2,380−100.0% | Sold out |
| Ropes Wealth Advisors LLC | 0 | $0 | 0.00% | −2,350−100.0% | Sold out |
| Pictet & Cie (Europe) SA | 0 | $0 | 0.00% | −2,308−100.0% | Sold out |
| Personal Capital Advisors Corp | 0 | $0 | 0.00% | −2,168−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −2,006−100.0% | Sold out |
| Marotta Asset Management | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Bluestein R H & Co | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Robertson Stephens Wealth Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Wealth Effects LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Resources Investment Advisors, LLC. | 0 | $0 | 0.00% | −1,950−100.0% | Sold out |
| Change Path, LLC | 0 | $0 | 0.00% | −1,929−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −1,924−100.0% | Sold out |